PARP Inhibitors: Improving Outcomes in Metastatic Prostate Cancer
Two new trials exploring this approach ― olaparib in the PROpel trial and niraparib in the MAGNITUDE trial –― had slightly different results.
Source: medscape.com
Stay updated with breaking news from Fred Saab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Two new trials exploring this approach ― olaparib in the PROpel trial and niraparib in the MAGNITUDE trial –― had slightly different results.
A Twitter post calling out an exchange between a presenter and an attendee asking questions at the recent GUCS conference created a bit of a buzz.
In a sprawling three-hour long cinematic epic, “Drive My Car” tackles weighty issues of grief, fidelity and personal expression, all backed up by gorgeous filmmaking and technical presentation. However, despite